MetaCap

3M (MMM) vs ResMed (RMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

3M (MMM) has outperformed ResMed (RMD) over the past year, gaining 5.9% versus a loss of 6.0%. Over five years, MMM leads with a +21.3% price change compared with -6.2% for RMD. 3M is the larger company by market cap ($91.97 billion vs $33.14 billion), about 2.8 times the size, while ResMed is growing revenue faster (+9.9% vs +1.5%).

On valuation, ResMed trades at a lower forward P/E (17.8x vs 17.9x for 3M). 3M offers the higher dividend yield (1.72% vs 1.04%). ResMed converts more of its revenue into profit, with a net margin of 26.9% versus 13.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MMM+5.89%RMD-6.03%
+18%-6%-29%
Nov 21, 20251 yearNov 20, 2026
MMM+18.77%RMD-9.48%
+27%-14%-55%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MMM versus RMD key metrics
MetricMMMRMD
Share price$177.99$235.63
Market cap$91.97B$33.14B
1-day change-0.27%-0.53%
YTD return+11.17%-2.18%
1-year return+5.89%-6.03%
5-year return+21.28%-6.20%
P/E ratio (TTM)26.5721.46
Forward P/E17.9417.82
EPS (TTM)$6.70$10.98
Dividend yield1.72%1.04%
Annual dividend$3.07$2.46
Revenue (latest FY)$24.95B$5.65B
Revenue growth (YoY)+1.52%+9.85%
Net income (latest FY)$3.25B$1.52B
Gross margin39.91%61.06%
Operating margin18.55%33.37%
Net margin13.03%26.94%
52-week high$196.90$277.67
52-week low$139.34$180.27
Distance from 52-week high-9.60%-15.14%
Analyst consensusbuybuy
Avg. price target upside+9.00%+12.18%
Average volume3.28M1.30M
Shares outstanding516.73M140.66M
Employees60,50011,370
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • 3M is about 2.8 times larger than ResMed by market value ($91.97B vs $33.14B).
  • MMM has outperformed RMD by 11.9 percentage points over the past year.
  • ResMed is more profitable, keeping 26.9 cents of every revenue dollar as net income versus 13.0 cents for 3M.
  • ResMed grew revenue faster in its latest fiscal year (+9.85% vs +1.52%).

About 3M

MMM stock →

3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer.

Health Care · Medical/Dental Instruments · 60,500 employees

About ResMed

RMD stock →

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally.

Health Care · Medical/Dental Instruments · 11,370 employees

MMM vs RMD FAQ

Which is bigger, 3M or ResMed?

3M (MMM) is larger, with a market capitalization of $91.97B compared with $33.14B for ResMed (RMD).

Which stock has performed better over the past year, MMM or RMD?

MMM returned +5.89% over the past 12 months, compared with -6.03% for RMD (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, MMM or RMD?

RMD has the lower trailing P/E at 21.5, versus 26.6 for MMM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, 3M or ResMed?

3M has the higher yield at 1.72%, compared with 1.04% for ResMed.

Are 3M and ResMed in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons